VanEck Associates’s Crescent Capital BDC CCAP Stock Holding History
Bought
Maintained
Sold
Other funds holding CCAP
TCDRS
FNF
SLF
AM
RCM
CC
VanEck Associates's CCAP Position: Q2 2026 in Review
VanEck Associates increased its Crescent Capital BDC (CCAP) stake by 3.7% in Q2 2026, buying an estimated $72.5K and bringing the position to 165,366 shares worth $1.81M. The position accounts for ﹤0.01% of the portfolio, ranked #1054.
VanEck Associates first reported a position in CCAP in Q1 2024 and has held it in 10 quarters since. The position peaked at $2.23M in Q4 2025. 85 funds tracked by Wall St. Rank hold CCAP as of Q2 2026.
- VanEck Associates held 165,366 shares of Crescent Capital BDC worth $1.81M as of Q2 2026.
- VanEck Associates bought 5,936 Crescent Capital BDC shares in Q2 2026, an estimated $72.5K.
- Crescent Capital BDC made up ﹤0.01% of VanEck Associates's portfolio in Q2 2026, its #1054 holding.
- VanEck Associates first reported a position in Crescent Capital BDC in Q1 2024 and has held it in 10 quarters since.
- VanEck Associates's Crescent Capital BDC position peaked at $2.23M in Q4 2025.
- 85 funds tracked by Wall St. Rank held Crescent Capital BDC as of Q2 2026.
Based on VanEck Associates's 13F filing for Q2 2026, filed 14 Aug 2026.